Unknown

Dataset Information

0

SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients.


ABSTRACT: BACKGROUND:The involvement of SARS-CoV-2 antibodies in mediating immunopathogenetic events in COVID-19 patients has been suggested. By using several experimental approaches, we investigated the potential association between SARS-CoV-2 IgGs recognizing the spike (S) protein receptor-binding domain (RBD), neutralizing antibodies (NtAb) targeting S, and COVID-19 severity. PATIENTS AND METHODS:This unicenter, retrospective, observational study included 51 hospitalized patients (24 at the intensive care unit; ICU). A total of 93 sera from these patients collected at different time points from the onset of symptoms were analyzed. SARS-CoV-2 RBD IgGs were quantitated by ELISA and NtAb50 titers were measured in a GFP reporterbased pseudotyped virus platform. Demographic and clinical data, complete blood counts, as well as serum levels of ferritin, Dimer-D, C reactive protein (CRP), lactose dehydrogenase (LDH), and interleukin-6 (IL-6) were retrieved from clinical charts. RESULTS:The overall correlation between levels of both antibody measurements was good (Rho?=?0.82; P?=?0?0.1). Four ICU patients died; two of these achieved NtAb50 titers ?1/160 while the other two exhibited a 1/80 titer. Very weak (Rho=>0.0-<0.2) or weak (Rho=>0.2-<0.4) correlations were observed between anti-RBD IgGs, NtAb50, and serum levels pro-inflammatory biomarkers. CONCLUSIONS:The data presented herein do not support an association between SARS-CoV-2 RBD IgG or NtAb50 levels and COVID-19 severity.

SUBMITTER: Gozalbo-Rovira R 

PROVIDER: S-EPMC7459327 | biostudies-literature | 2020 Oct

REPOSITORIES: biostudies-literature

altmetric image

Publications

SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients.

Gozalbo-Rovira Roberto R   Gimenez Estela E   Latorre Víctor V   Francés-Gómez Clara C   Albert Eliseo E   Buesa Javier J   Marina Alberto A   Blasco María Luisa ML   Signes-Costa Jaime J   Rodríguez-Díaz Jesús J   Geller Ron R   Navarro David D  

Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology 20200901


<h4>Background</h4>The involvement of SARS-CoV-2 antibodies in mediating immunopathogenetic events in COVID-19 patients has been suggested. By using several experimental approaches, we investigated the potential association between SARS-CoV-2 IgGs recognizing the spike (S) protein receptor-binding domain (RBD), neutralizing antibodies (NtAb) targeting S, and COVID-19 severity.<h4>Patients and methods</h4>This unicenter, retrospective, observational study included 51 hospitalized patients (24 at  ...[more]

Similar Datasets

| S-EPMC8897556 | biostudies-literature
| S-EPMC9511452 | biostudies-literature
| S-SCDT-EMM-2022-15904 | biostudies-other
| S-EPMC8200723 | biostudies-literature
| S-SCDT-10_1038-S44318-024-00061-0 | biostudies-other
| S-EPMC7600936 | biostudies-literature
| S-EPMC9122311 | biostudies-literature
2021-07-07 | GSE161810 | GEO
| S-EPMC8159068 | biostudies-literature